Nicox
Gavin Spencer is a seasoned executive with extensive experience in the pharmaceutical and ophthalmic industries, currently serving as the Chief Executive Officer at Nicox since February 2005. Under Gavin Spencer's leadership, Nicox has undergone significant restructuring to optimize its focus on clinical assets and future strategies. Prior roles include Executive Vice President and Chief Business Officer, where responsibilities encompassed corporate development, investor relations, and strategic planning. Additionally, Gavin Spencer has provided business advice to Parkure, a company dedicated to finding a cure for Parkinson’s disease, and has served on the boards of various organizations such as Altacor. Educational qualifications include a Bachelor’s Degree and a Doctor of Philosophy in Chemistry from the University of Aberdeen.
Nicox
Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com